Consumers who purchased Tom’s of Maine toothpaste at any point since 2020 can now file claims for cash from a $2.9 million class-action settlement against parent company Colgate-Palmolive, and no receipt is required. The deadline to submit a claim is August 27. The case, filed in the Eastern District of New York, follows an FDA inspection that uncovered bacterial contamination at the brand’s manufacturing plant in Sanford, Maine.
FDA bacteria findings and the path to a $2.9 million deal
The settlement traces directly to what federal inspectors found inside the Sanford facility. Between May 7 and May 22, 2024, the FDA conducted an inspection of the Colgate-Palmolive and Tom’s of Maine plant. Inspectors identified Pseudomonas aeruginosa, an opportunistic pathogen, in water samples used during the manufacturing process. The agency determined the company had failed to follow current good manufacturing practice (CGMP) requirements, and on November 5, 2024, the FDA issued a warning letter to Colgate-Palmolive and Tom’s of Maine.
The FDA inspection and subsequent enforcement action were later described in coverage by a national newspaper, which highlighted how the contamination concerns triggered both regulatory scrutiny and consumer litigation. According to that reporting, regulators focused on the plant’s water system and sanitation controls, concluding that the company needed to overhaul aspects of its manufacturing oversight to comply with CGMP standards.
The warning letter became the evidentiary backbone of the lawsuit. Plaintiffs alleged that consumers paid full price for toothpaste produced under conditions that did not meet federal safety standards, even if the products themselves were not individually tested for contamination before sale. The case, Rabinowitz et al v. Colgate-Palmolive Company et al., was docketed as USCOURTS-nyed-2_25-cv-06996 in the U.S. District Court for the Eastern District of New York. As reflected in the federal docket, the court granted preliminary approval of the $2.9 million settlement, conditionally certified the settlement class, appointed class counsel, and named Epiq as the claims administrator. A final approval hearing date and briefing schedule have been set, though the settlement will not become final until the judge signs off after that hearing.
Under the agreement, Colgate-Palmolive and Tom’s of Maine do not admit wrongdoing but agree to fund the settlement and to continue working with regulators on compliance. The deal is structured as a non-reversionary common fund, meaning that after court-approved fees, costs, and any service awards to class representatives are deducted, the remaining money will be distributed to eligible consumers rather than returning to the company.
What the settlement means for buyers without receipts
The structure of this deal is designed to lower the barrier for participation. Claimants do not need to produce a receipt or other proof of purchase to file. The multi-year purchase window, stretching back to 2020, covers a wide range of consumers who bought any qualifying Tom’s of Maine toothpaste product during that period, including different flavors, sizes, and formulations sold in major retailers and online. Epiq, the court-appointed administrator, will handle online and mail-in claim processing, review submissions for eligibility, and oversee the eventual distribution of funds once the settlement becomes effective.
For anyone who qualifies, the first step is straightforward: submit a claim before the August 27 cutoff. Claim forms typically ask consumers to attest, under penalty of perjury, to when and where they bought Tom’s of Maine toothpaste and how many units they purchased during the covered period. The amount each claimant receives will depend on how many valid claims are filed against the $2.9 million fund, minus attorney fees, administrative costs, and any court-approved service awards. No public data yet shows the expected per-person payout, and direct statements from class counsel on individual payment estimates have not appeared in the government-hosted court filings.
Because there is no receipt requirement and the class period spans several years, participation could be high. In similar consumer settlements, that combination of a long window and low documentation threshold tends to increase the number of claims, which in turn can dilute the amount each person ultimately receives. If claim volume is lower than expected, however, individual payments could be higher, or the administrator may apply a second distribution round to those who already filed valid claims, depending on the terms the court approves.
The case also raises a broader question about how CGMP-related settlements perform in practice. A multi-year purchase window paired with no-receipt filing tends to attract high claim volumes, which dilutes individual payouts. Once Epiq publishes final distribution data after the case closes, that information could become a reference point for how contamination-linked consumer suits translate into real-world compensation, and whether these cases meaningfully change how companies manage manufacturing risks.
For now, consumers who bought Tom’s of Maine toothpaste since 2020 face a simple decision: file a claim before the deadline or forgo a share of the settlement fund. Those who want to participate should review the settlement website and instructions carefully, ensure their contact information is accurate, and keep a copy of their submitted claim in case of follow-up questions. While the payments may ultimately be modest on an individual basis, the case underscores how regulatory findings can quickly migrate into the civil courts – and how everyday purchases can end up at the center of national scrutiny when manufacturing standards fall short.
